Lv1
40 积分 2024-08-25 加入
Dupilumab cuts both ways
1个月前
已关闭
Dupilumab unmasking cutaneous T‐cell lymphoma; report of a fatal case
1个月前
已完结
Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma
1个月前
已完结
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma
1个月前
已完结
Cutaneous T-cell lymphoma following dupilumab use – A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)
2个月前
已完结
No association between omalizumab use and risk of cancer: a nationwide registry‐based cohort study
2个月前
已完结
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)
2个月前
已完结
皖公网安备34019202002308
